furosemide has been researched along with Diabetic Glomerulosclerosis in 38 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Captopril is a valuable new drug for treating hypertension in insulin dependent diabetics with nephropathy." | 6.66 | Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. ( Hommel, E; Parving, HH; Smidt, UM, 1988) |
| "Given a similar level of arterial pressure control, both lisinopril and diltiazem slow progression of diabetic renal disease and reduce albuminuria to a greater extent than does the combination of a loop diuretic and beta-adrenoreceptor antagonist." | 5.07 | Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. ( Bakris, GL; Sadler, R; Slataper, R; Vicknair, N, 1993) |
| "A 66-year-old hypertensive diabetic patient with latent hypoaldosteronism and mild renal failure was treated by adding enalapril, an angiotensin converting enzyme inhibitor, to the furosemide and nifedipine regimen because of an insufficient antihypertensive response for 1 month." | 3.69 | Reversible hyperkalemia during antihypertensive therapy in a hypertensive diabetic patient with latent hypoaldosteronism and mild renal failure. ( Azukizawa, S; Kaneko, M; Kigoshi, T; Matsui, A; Morimoto, S; Nakano, S; Uchida, K, 1994) |
| "Other than for early diabetic nephropathy, a solid physiological basis for these effects in advanced nephropathy is lacking." | 2.82 | Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF System. ( Braam, B; Hamza, S; Poursharif, S, 2022) |
| "Captopril is a valuable new drug for treating hypertension in insulin dependent diabetics with nephropathy." | 2.66 | Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. ( Hommel, E; Parving, HH; Smidt, UM, 1988) |
| "When introduced early in the course of diabetic nephropathy, ACEIs appear to produce greater reductions in urinary protein concentrations than do other antihypertensive agents, even when systemic blood pressure does not decrease." | 2.38 | Use of angiotensin-converting-enzyme inhibitors in the management of renal disease. ( Asher, JP; Murray, KM, 1991) |
| "Patients with diabetic nephropathy develop nephrotic syndrome and may show limited response to conventional therapy." | 1.48 | Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide. ( Hoshiyama, A; Kamata, Y; Masaki, T; Shichiri, M; Takada, T; Toki, T, 2018) |
| "Type 2 diabetic kidney disease (DKD) is frequently accompanied by uncontrollable hypertension due to the sodium sensitivity inherent in DKD and to diuretic-resistant edema." | 1.42 | Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease. ( Hirai, K; Hoshino, T; Ito, K; Kaku, Y; Miyazawa, H; Mori, H; Ookawara, S; Tabei, K; Ueda, Y; Yoshida, I, 2015) |
| "Furosemide treatment significantly increased the urinary protein excretion when compared with the normal rats." | 1.40 | Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy. ( Afrin, R; Arumugam, S; Giridharan, VV; Harima, M; Karuppagounder, V; Miyashita, S; Pitchaimani, V; Sreedhar, R; Suzuki, K; Thandavarayan, RA; Watanabe, K, 2014) |
| "Eighteen hypertensive IDDM patients with diabetic nephropathy, who had not been treated previously, were followed during 3 years of treatment with captopril and frusemide or bendrofluazide." | 1.29 | Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. ( Hommel, E; Parving, HH; Rossing, P; Smidt, UM, 1994) |
| "Six of the diabetic patients with acute renal failure recovered; two required hemodialysis, never regaining self-sustaining renal function." | 1.25 | Acute renal failure after excretory urography in diabetic patients. ( Diaz-Buxo, JA; Hattery, RR; Palumbo, PJ; Wagoner, RD, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (44.74) | 18.7374 |
| 1990's | 10 (26.32) | 18.2507 |
| 2000's | 2 (5.26) | 29.6817 |
| 2010's | 8 (21.05) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Poursharif, S | 1 |
| Hamza, S | 1 |
| Braam, B | 1 |
| Takada, T | 1 |
| Masaki, T | 1 |
| Hoshiyama, A | 1 |
| Toki, T | 1 |
| Kamata, Y | 1 |
| Shichiri, M | 1 |
| Peng, XG | 1 |
| Bai, YY | 1 |
| Fang, F | 1 |
| Wang, XY | 1 |
| Mao, H | 1 |
| Teng, GJ | 1 |
| Ju, S | 1 |
| Hoshino, T | 1 |
| Ookawara, S | 1 |
| Miyazawa, H | 1 |
| Ito, K | 1 |
| Ueda, Y | 1 |
| Kaku, Y | 1 |
| Hirai, K | 1 |
| Mori, H | 1 |
| Yoshida, I | 1 |
| Tabei, K | 1 |
| Arumugam, S | 1 |
| Sreedhar, R | 1 |
| Miyashita, S | 1 |
| Karuppagounder, V | 1 |
| Thandavarayan, RA | 1 |
| Giridharan, VV | 1 |
| Pitchaimani, V | 1 |
| Afrin, R | 1 |
| Harima, M | 1 |
| Suzuki, K | 1 |
| Watanabe, K | 1 |
| Babelova, A | 1 |
| Burckhardt, BC | 1 |
| Wegner, W | 1 |
| Burckhardt, G | 1 |
| Henjakovic, M | 1 |
| Sourbron, S | 1 |
| Kujal, P | 1 |
| Chábová, VČ | 1 |
| Vernerová, Z | 1 |
| Walkowska, A | 1 |
| Kompanowska-Jezierska, E | 1 |
| Sadowski, J | 1 |
| Vaňourková, Z | 1 |
| Husková, Z | 1 |
| Opočenský, M | 1 |
| Skaroupková, P | 1 |
| Schejbalová, S | 1 |
| Kramer, HJ | 1 |
| Rakušan, D | 1 |
| Malý, J | 1 |
| Netuka, I | 1 |
| Vaněčková, I | 1 |
| Kopkan, L | 1 |
| Cervenka, L | 1 |
| Kuriyama, S | 1 |
| Otsuka, Y | 1 |
| Ueda, H | 1 |
| Sugano, N | 1 |
| Yoshizawa, T | 1 |
| Yamada, T | 1 |
| Hosoya, T | 1 |
| Ries, M | 1 |
| Basseau, F | 1 |
| Tyndal, B | 1 |
| Jones, R | 1 |
| Deminière, C | 1 |
| Catargi, B | 1 |
| Combe, C | 1 |
| Moonen, CW | 1 |
| Grenier, N | 1 |
| BERMAN, LB | 1 |
| EBRAHIMI, A | 1 |
| Dussol, B | 1 |
| Morange, S | 1 |
| Loundoun, A | 1 |
| Auquier, P | 1 |
| Berland, Y | 1 |
| Sugiyama, H | 1 |
| Uchimura, I | 1 |
| Odakura, T | 1 |
| Maezawa, H | 1 |
| Parving, HH | 6 |
| Rossing, P | 3 |
| Hommel, E | 6 |
| Smidt, UM | 4 |
| Uchida, K | 2 |
| Azukizawa, S | 1 |
| Nakano, S | 1 |
| Kaneko, M | 1 |
| Kigoshi, T | 1 |
| Morimoto, S | 2 |
| Matsui, A | 1 |
| Gómez-Martino, JR | 1 |
| Miralles, JM | 1 |
| De Leon, B | 1 |
| Hernandez, MT | 1 |
| Tabernero, JM | 1 |
| Slataper, R | 1 |
| Vicknair, N | 1 |
| Sadler, R | 1 |
| Bakris, GL | 1 |
| Ling, BN | 1 |
| Matsunaga, H | 1 |
| Ma, H | 1 |
| Eaton, DC | 1 |
| Tamimi, NA | 1 |
| al-Heresh, AM | 1 |
| Rowland-Payne, CM | 1 |
| Mogensen, CE | 2 |
| Husberg, B | 1 |
| Hellsten, S | 1 |
| Bergentz, SE | 1 |
| Hansen, T | 1 |
| Möller-Jensen, K | 1 |
| Usukura, N | 1 |
| Kishitani, M | 1 |
| Yoshimitsu, K | 1 |
| Sagara, H | 1 |
| Takeda, R | 1 |
| Christlieb, AR | 1 |
| Kaldany, A | 1 |
| D'Elia, JA | 1 |
| Diaz-Buxo, JA | 1 |
| Wagoner, RD | 1 |
| Hattery, RR | 1 |
| Palumbo, PJ | 1 |
| Teschner, M | 1 |
| Schaefer, RM | 1 |
| Bahner, U | 1 |
| Heidland, A | 1 |
| Asher, JP | 1 |
| Murray, KM | 1 |
| Larsen, M | 1 |
| Lund-Andersen, H | 1 |
| Mathiesen, ER | 1 |
| Cruz, C | 1 |
| Hricak, H | 1 |
| Samhouri, F | 1 |
| Smith, RF | 1 |
| Eyler, WR | 1 |
| Levin, NW | 1 |
| Nakahama, H | 1 |
| Orita, Y | 1 |
| Izumi, M | 1 |
| Fukuhara, Y | 1 |
| Kamada, T | 1 |
| Miwa, Y | 1 |
| Yamaji, A | 1 |
| Kolomoiskaia, MB | 1 |
| Garagan, SF | 1 |
| Kolesnikov, IuP | 1 |
| Muth, RG | 1 |
| Martinez-Maldonado, M | 1 |
| Eknoyan, G | 1 |
| Suki, WN | 1 |
| Relkin, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Oral Sodium Chloride vs iv Sodium Chloride in the Prevention of Contrast Nephropathy in Outpatients[NCT03476460] | Phase 2 | 269 participants (Actual) | Interventional | 2014-03-01 | Completed | ||
| Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for furosemide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF System.
Topics: Acetazolamide; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetic | 2022 |
Role of growth factors in mesangial cell ion channel regulation.
Topics: Angiotensin II; Animals; Calcium; Chloride Channels; Cyclosporine; Diabetic Nephropathies; Endotheli | 1995 |
[Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Dia | 1992 |
Use of angiotensin-converting-enzyme inhibitors in the management of renal disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Connective Tissue Diseases; Diabetic Nephropathies; Furose | 1991 |
Diuretics in nonedematous states. Physiological basis for the clinical use.
Topics: Acidosis, Renal Tubular; Barbiturates; Calcium; Chlorothiazide; Cystinuria; Diabetes Insipidus; Diab | 1973 |
5 trials available for furosemide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Bendroflumethiazide; Blood Pressure; C | 1995 |
Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Topics: Adult; Albuminuria; Antihypertensive Agents; Cohort Studies; Diabetic Nephropathies; Female; Forecas | 1994 |
Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.
Topics: Albuminuria; Antihypertensive Agents; Atenolol; Diabetic Nephropathies; Diltiazem; Dipeptides; Furos | 1993 |
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Typ | 1988 |
28 other studies available for furosemide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diabetic Nephropathies; Drug Resistan | 2018 |
Renal lipids and oxygenation in diabetic mice: noninvasive quantification with MR imaging.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Furosemide; Kidney; Lipid Metaboli | 2013 |
Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabeti | 2015 |
Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy.
Topics: Animals; Blood Glucose; Body Weight; Diabetic Nephropathies; Disease Models, Animal; Diuretics; Echo | 2014 |
Sex-differences in renal expression of selected transporters and transcription factors in lean and obese Zucker spontaneously hypertensive fatty rats.
Topics: Animals; Biological Transport; Blood Pressure; Cyclic GMP; Diabetes Mellitus; Diabetic Nephropathies | 2015 |
Compartmental modelling for magnetic resonance renography.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Computer Simulation; Cyclooxygenase I | 2010 |
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2010 |
Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Co | 2011 |
Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Diuretics; Furosemide; Kidney; Magnetic Resonanc | 2003 |
EXPERIENCES WITH FUROSEMIDE IN RENAL DISEASE.
Topics: Biomedical Research; Blood Urea Nitrogen; Creatine; Creatinine; Diabetic Nephropathies; Diuretics; D | 1965 |
Plasma renin and aldosterone in adult-onset diabetics with persistent proteinuria.
Topics: Aldosterone; Angiotensin II; Bed Rest; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropat | 1981 |
Reversible hyperkalemia during antihypertensive therapy in a hypertensive diabetic patient with latent hypoaldosteronism and mild renal failure.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Furos | 1994 |
Urinary prostaglandins (PGE2 and PGI2) in hyporeninaemic hypoaldosteronism in diabetic patients with chronic renal failure.
Topics: Aldosterone; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dinoprostone; Epoprosten | 1994 |
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
Topics: Adult; Albuminuria; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Captopril; Diabete | 1994 |
Dropsical bullae in patients with diabetes mellitus and chronic renal failure receiving high-dose frusemide.
Topics: Adult; Aged; Blister; Diabetic Nephropathies; Dose-Response Relationship, Drug; Edema; Female; Furos | 1995 |
Diabetes and hypertension.
Topics: Blood Pressure; Diabetes Mellitus; Diabetic Nephropathies; Furosemide; Glomerular Filtration Rate; H | 1979 |
Massive diuresis after renal transplantation due to retention of furosemide.
Topics: Adult; Creatinine; Diabetic Nephropathies; Female; Furosemide; Half-Life; Humans; Kidney Failure, Ch | 1977 |
[The responsiveness of plasma renin activity to furosemide administration in diabetic patients (author's transl)].
Topics: Adult; Aged; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathie | 1978 |
Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.
Topics: Adolescent; Adult; Albuminuria; Diabetic Nephropathies; Furosemide; Glomerular Filtration Rate; Huma | 1976 |
Plasma renin activity and hypertension in diabetes mellitus.
Topics: Adult; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Female; Furosemide; Humans | 1976 |
Acute renal failure after excretory urography in diabetic patients.
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Diabetic Nephropathies; Female; Furosemide; Humans; Ma | 1975 |
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Capto | 1989 |
Converting enzyme-inhibition in diabetic nephropathy.
Topics: Albuminuria; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Therapy, Combination; Furosemid | 1989 |
Contrast media for angiography: effect on renal function.
Topics: Adolescent; Adult; Age Factors; Aged; Angiography; Blood Urea Nitrogen; Creatinine; Diabetic Angiopa | 1986 |
Urinary excretion of frusemide and its metabolites in a diabetic nephropathy patient.
Topics: Aged; Diabetic Nephropathies; Furosemide; Humans; Male | 1988 |
[Furosemide in the complex treatment of patients with diabetic nephropathy].
Topics: Adult; Combined Modality Therapy; Diabetic Nephropathies; Female; Furosemide; Humans; Male; Middle A | 1987 |
Diuretic properties of furosemide in renal disease.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aged; Amyloidosis; Blood Urea Nitrogen; Creatine; Diabetic | 1968 |
Inherited forms of diabetes insipidus and diagnostic drug applications.
Topics: Blood Volume; Cell Membrane Permeability; Chlorothiazide; Chlorpropamide; Diabetes Insipidus; Diabet | 1968 |